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Abstract Optogenetics is a rapidly evolving Weld of tech-
nology that allows optical control of genetically targeted
biological systems at high temporal and spatial resolution.
By heterologous expression of light-sensitive microbial
membrane proteins, opsins, cell type-speciWc depolariza-
tion or silencing can be optically induced on a millisecond
time scale. What started in a petri dish is applicable today
to more complex systems, ranging from the dissection of
brain circuitries in vitro to behavioral analyses in freely
moving animals. Persistent technical improvement has
focused on the identiWcation of new opsins, suitable for
optogenetic purposes and genetic engineering of existing
ones. Optical stimulation can be combined with various
readouts deWned by the desired resolution of the experi-
mental setup. Although recent developments in optogenet-
ics have largely focused on neuroscience it has lately been
extended to other targets, including stem cell research and
regenerative medicine. Further development of optogenetic
approaches will not only highly increase our insight into
health and disease states but might also pave the way for a
future use in therapeutic applications.
Keywords Optogenetics · Rhodopsin · 
Channelrhodopsin · Halorhodopsin · Optical tools · 
Arch · ChR2 · NpHR
Introduction
In recent years, optical control of genetically targeted bio-
logical systems has been a fast moving Weld of continuous
progress. The combination of optics, genetics and bioengi-
neering to either stimulate or inhibit cellular activity via
light-sensitive microbial membrane proteins (opsins) gave
birth to a new research discipline named “optogenetics”
(Nagel et al. 2002, 2003; Boyden et al. 2005; Deisseroth
et al. 2006). Optical control by microbial opsins has several
advantages in comparison to classical electrical or multi-
component manipulation techniques. By genetic targeting,
optogenetic stimulation and even inhibition of heteroge-
neous brain tissue can be achieved in a cell type-speciWc
manner. In contrast, electrical stimulation unselectively
interferes with all present cell types, regardless of their ana-
tomical or genetic entity (for example excitatory versus
inhibitory neurons and local neurons versus projections),
thereby diluting the contribution of individual elements on
brain circuitries on the overall eVect. In opsins, sensor and
eVector are combined in a monocomponent system and no
exogenous genetical or chemical substitution is necessary
what makes it more suitable for in vivo experiments in con-
trast to multicomponent systems, which are limited rather to in
vitro applications. As light of moderate intensity does not
interfere with neuronal function and opsin latency upon illu-
mination is very short, optogenetics uniquely combines cell
type-speciWc control with millisecond time scale temporal
resolution in a fully reversible manner. Once channelrho-
dopsin 2 (ChR2) and halorhodopsin (NpHR) had been
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recognized as multimodal optical interrogation tools in
neuroscience, signiWcant eVorts have been made to lift the
optogenetic approach to a level of broader applicability
(Nagel et al. 2003; Boyden et al. 2005; Deisseroth et al.
2006; Zhang et al. 2007a). Bioengineering of existing opsin
genes from diVerent microorganisms generated a variety of
chimeric rhodopsin versions with modiWed properties
regarding traYcking, kinetics and light responsivity (Zhao
et al. 2008; Airan et al. 2009; Berndt et al. 2008, 2011; Lin
et al. 2009; Bamann et al. 2010; Gunaydin et al. 2010;
Oh et al. 2010; Han et al. 2011; Kleinlogel et al. 2011;
Schultheis et al. 2011; Yizhar et al. 2011a, b). In parallel,
opsins from various species were screened for their optoge-
netic suitability. Channelrhodopsin from diVerent species
extended the optical spectrum of cellular excitation and the
light-driven proton pumps Arch and ArchT enabled neuro-
nal silencing in addition to halorhodopsin (Zhang et al.
2008; Chow et al. 2010; Govorunova et al. 2011; Han et al.
2011). Starting with proof of principle experiments in frog
oocytes, optogenetics has been intensively used in vitro
(Nagel et al. 2002; Boyden et al. 2005). With the creation
of an optical neural interface, freely moving mammals can be
studied in vivo, upgrading the optogenetic toolbox to an
instrument for the analysis of such complex biological
mechanisms such as animal behavior (for example Aravanis
et al. 2007; Adamantidis et al. 2007; Tsai et al. 2009; Carter
et al. 2010; Ciocchi et al. 2010; Tye et al. 2011). Beside its
role in neuroscience, other research Welds recently have
started to illuminate ChR2-targeted tissues such as cardio-
myocytes and embryonic stem cells, proving the universal
capabilities of optogenetics (Bruegmann et al. 2010; Stroh
et al. 2011). Continuous progress in optical technologies and
opsin engineering will not only further consolidate optoge-
netics as an excellent experimental tool but will also lay the
foundation for potential future therapeutic applications (Bi
et al. 2006; Lagali et al. 2008; Llewellyn et al. 2010; Weick
et al. 2010; Kleinlogel et al. 2011) (Table 1).
Exploiting light-sensitive microbial membrane proteins
With the identiWcation of the gene for a light-responsive
membrane protein in microorganisms called bacteriorho-
dopsin (BR), Stoeckenius and Oesterhelt (1971) set the
foundation for a technology, which is today described by the
term “optogenetics” (Oesterhelt and Stoeckenius 1973;
Deisseroth et al. 2006). Three decades had passed until sci-
entists were able to take advantage of the potential based on
the working principle of this seven-transmembrane domain-
containing light-transducing proton pump, which in nature
serves microbes, among other things, as a regulator of
homeostasis and phototrophy (Beja et al. 2000). Encoded by
a single open reading frame, it works as an optical controller
of transmembrane ion Xow combining fast action and
coupling of sensor and eVector in a monocomponent
system (Oesterhelt and Stoeckenius 1971). Later rhodopsin-
mediated responses were also studied in the alga
Chlamydomonas (Harz and Hegemann 1991) and since the
photocurrets were ultra fast the authors claimed that rho-
dopsin and channel were intimately linked (Holland et al.
1996). Then Nagel and colleagues proved this concept by
showing that the Rhodopsins are directly light-gated ion
channels. They used amphibian and mammalian cells as
hosts to express channelrhodopsin-1 (ChR1), a light-gated
proton channel from the green algae Chlamydomonas rein-
hardtii. In a modiWed patch clamp set-up they substantiated
that rhodopsins react functionally upon laser illumination
also in mammalian cells (Nagel et al. 2002). What was
initially used as an experimental model system to study
channelrhodopsin function turned into the precursor of a
novel scientiWc tool. With the functional characterization of
ChR2, a directly light-gated cation-selective membrane
channel, Nagel et al. (2003) showed that mammalian cells
expressing ChR2 could be depolarized “simply by illumi-
nation”. The full conversion of this approach into an optical
control device of cell activity happened in 2005 when it
found its way into neuroscience. The Deisseroth lab applied
lentiviral gene delivery to express ChR2 in rat hippocampal
neurons. In combination with high-speed optical switching,
neuronal spiking was elicited by photostimulation in a mil-
lisecond timescale (Boyden et al. 2005). In parallel, the labs
of Yawo, Herlitze and Gottschalk independently demon-
strated the feasibility of ChR2-based optical neuronal
manipulation (Li et al. 2005; Nagel et al. 2005; Ishizuka
et al. 2006). The interplay of optics, genetics, and bioengi-
neering in this novel approach was the inspiration to coin
the term “optogenetics”, which can be deWned as optical
control of cells achieved by the genetic introduction of
light-sensitive proteins (Deisseroth et al. 2006). Another
milestone in the evolution of optical control was the discov-
ery of an inhibitory opponent of ChR2. Although relative
reduction of neuronal activity had previously been shown
for the Gi/o protein-coupled vertebrate rat opsin (Ro4, a
type II opsin) by activating G protein-gated rectifying potas-
sium channels and voltage-gated calcium channels (Li et al.
2005), complete and fast silencing was achieved by using a
microbial (type I opsin) chloride pump. Halorhodopsin
(HR) had been discovered decades before its conversion
into a research tool (Matsuno-Yagi and Mukohata 1977).
Expression of Natromonas pharaonis HR (NpHR) in neuronal
tissue enables optically induced cellular hyperpolarization
by pumping chloride into the cell. Consecutive inhibition of
spontaneous neuronal Wring can be achieved in a millisec-
ond time scale (Zhang et al. 2007a, b; Han and Boyden
2007). A major advantage compared to Ro4 is the manipu-
lation via Cl¡, an ion that is not involved in intracellularMol Genet Genomics (2012) 287:95–109 97
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signaling such as calcium and the use of all-trans retinal
instead of 11-cis which is functioning as a chromophore in
Ro4. Due to spectrally separated activation maxima of
ChR2 and NpHR bidirectional optical modulation is possi-
ble, oVering excitation and silencing of the same target cell.
Even more eYcient optical silencers, the proton pumps
Arch and ArchT, with similar activation spectra were found
in archaebacteria after screening various species (prokary-
otes, algae and fungi) for microbial type I opsins (Chow
et al. 2010; Han et al. 2011). In an attempt to establish a
simultaneous multi-excitatory optical control system by
using spectrally separated opsins, red-shifted ChR1 from
Volvox carteri (VChR1) was identiWed. VChR1 works like
ChR2 as a cation channel and extended the optical spectrum of
cellular excitation toward green light (Zhang et al. 2008).
Yet VChR1 applicability in mammalian cells was strongly
limited by small photocurrents due to insuYcient mem-
brane expression; a limitation that has been circumvented
by the generation of a chimeric channelrhodopsin (C1V1)
composed of channelrhodopsin-1 parts from Chlamydo-
monas reinhardtii and Volvox carteri (Yizhar et al. 2011b).
In a very recent publication a new channelrhodopsin from
Mesostigma viride (MChR1) with a similarly red-shifted
action spectrum has been identiWed and mutated (Govoru-
nova et al. 2011). Heterologous expression of native
MChR1 in HEK293 cells indicated peak currents compara-
ble to VChR1 with faster current kinetics making MChR1 a
potential candidate for red-shifted optogenetic control,
although toxicity and expression levels in neuronal tissue
remain to be analyzed. Channelrhodopsins show structural
homology to other type I opsins, however, in their working
principle they fundamentally diVer from NpHR and BRs
like Arch and ArchT (Fig. 1). ChRs are non-selective cation
channels that open when illuminated by green light with
passive inXux of predominantly Na+ and, to a lesser extent,
Ca2+ ions along a membrane gradient resulting in the depo-
larization of cells expressing these molecules (Nagel et al.
2003). In contrast, HR and BR are ion pumps that work
against an electrochemical gradient across the membrane
(Racker and Stoeckenius 1974, Schobert and Lanyi 1982).
With an excitation maximum at 589 nm NpHR pumps
chloride into the cell when activated by yellow light caus-
ing a hyperpolarization with consecutive silencing of the
target cell. Arch and ArchT also hyperpolarize cells, but by
pumping H+ outwards and in a more rapidly recovering
manner. Excitation maxima are at approximately 566 nm
for Arch and ArchT (Chow et al. 2010; Han et al. 2011).
Adjusting microbial opsins to optogenetic needs
While opsins are designed as the perfect single unit optical
regulators of membrane Xow in microbes, more complex
organisms such as vertebrates in contrast use multicompo-
nent systems of information signaling or energy transduc-
tion. After the identiWcation of promising optogenetic
candidates, several hurdles had to be smoothed out in order
to maximize the compatibility of membrane proteins of
microbial origin with their use in mammalian cells. In this
regard the transformation of the optogenetic silencing tool
NpHR into its updated version eNpHR 3.0, very well exem-
pliWes several aspects of genetic opsin engineering. In order
to optimize opsin expression in mammalian cells a codon-
optimized variant of NpHR was created in analogy to ChR2
(Boyden et al. 2005; Zhang et al. 2007a). In contrast to the
eYcient expression of NpHR-EYFP fusion proteins in rat
hippocampal neurons in vitro, expression of native NpHR
under a strong ubiquitous promoter in mammalian cells in
vivo lead to retention in the endoplasmic reticulum causing
toxic intracellular accumulation (Zhang et al. 2007a; Zhao
et al. 2008). By adding a vertebrate export motif c-termi-
nally, eNpHR 2.0 was generated, resulting in decreased
intracellular blebbing and improved membrane traYcking
(Gradinaru et al. 2008). After analyzing various transport
signals, another c-terminal modiWcation Wnally brought the
breakthrough. eNpHR 3.0 contains an additional traYcking
signal leading to improved membrane targeting both at the
soma as well as in cellular processes. Consecutive to well
tolerated high level in vivo expression of eNpHR 3.0,
higher photocurrents can be measured in targeted mamma-
lian neuronal tissue compared to the non-tuned NpHR
(Gradinaru et al. 2010). Up to now bioengineering of opto-
genetic silencers focused on improving opsin expression
and the mentioned principles seem applicable to proton
pumps such as Arch as well. Indeed, equipping the original
version of BR with an export motive and traYcking signal
converted BR from an intracellular accumulator into the
optogenetic tool eBR (Gradinaru et al. 2010). In contrast,
optimizing the photocycle kinetics in pumps is more diY-
cult since a slow down of the photocycle automatically
translates into a lower pump activity.
Creating high-end optogenetic tools
Engineering of rhodopsins was Wrst introduced by Nagel
et al. (2003). Mutating the amino acid 123 from glutamate
to glutamine resulted in altered photocurrents of ChR2
when expressed in oocytes from Xenopus laevis. For the
use in mammalian neurons codon optimization led to sig-
niWcantly higher expression levels compared to codons
used in algae (Boyden et al. 2005; Gradinaru et al. 2007).
As high opsin expression is a prerequisite for suprathresh-
old depolarization, initial modiWcations focused on boost-
ing photocurrents. Substitution of arginine by histidine at
position 134 (H134R) doubled current size by delayed100 Mol Genet Genomics (2012) 287:95–109
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channel closure, but the doubled oV-kinetics led to impaired
temporal precision (Boyden et al. 2005; Gradinaru et al.
2007; Lin et al. 2009). Wild-type hChR2 works reliably in
a frequency ranging from 1 to 20 Hz. In order to improve
channelrhodopsin accuracy also in a higher frequency
range, site-directed mutated variants of ChR2 were tested
for their optogenetic qualities, identifying CHETA. Muta-
tion at position 123 in CHETA (E123T or A) led to
increased steady state-to-peak current ratio and faster oV-
kinetics, resulting in precise spike trains up to 120 Hz. In
line with the aforementioned example the advantage of
high frequent and temporally precise stimulation was
traded against a reduced peak current (Gunaydin et al.
2010). An approach to circumvent loss of current and repet-
itive spiking Wdelity by improving frequency was the gen-
eration of chimeric hybrids of ChR1 and ChR2 (ChIEF)
with reduced desensitization, stronger currents and reliable
spiking beyond 20 Hz (Lin et al. 2009). After transferring
crystallographic observations made in BRs to channelrho-
dopsins, step-function opsins (SFOs) were generated by
site-directed point mutation of the cytosine in position 128
(Berndt et al. 2008; Bamann et al. 2010). Modifying the
hypothetical chromophore binding pocket slowed down the
photocycle kinetics by means of extending the conducting
state up to nearly 2 min for certain mutations (C128S).
Thereby, long-time depolarization is induced far beyond
the pulse duration of illumination. Inactivation during this
period of prolonged activation can be achieved by pulses of
560 nm light. In a recent publication, C128 mutants have
been used for the induction of prolonged depolarization (up
to even days after repetitive stimulation) in muscle cells
and neurons from Caenorhabditis elegans, thereby trigger-
ing long-term behavioral eVects and inXuencing animal
development (Schultheis et al. 2011). Similar eVects are
observed with the D156A mutation in the fourth transmem-
brane domain (Bamann et al. 2010) and the combination of
both SFO mutations resulted in remarkable stability of the
active state up to 30 min (Yizhar et al. 2011b).
Another possibility of long-term manipulation is the tar-
geting of G protein-mediated intracellular signaling cas-
cades with novel optogenetic tools such as chimeric
rhodopsins fused to G protein-coupled receptors also
known as optoXRs or RH-CTs. By exchanging the intracel-
lular loops of the native rhodopsin with corresponding ones
Fig. 1 The optogenetic princi-
ple: changing the membrane 
voltage potential of excitable 
cells. a Activating tools—chan-
nelrhodopsins: channelrhodop-
sin-2 from Chlamydomoas 
reinhardtii (ChR2) and channel-
rhodopsin-1 Volvox carteri 
(VChR1) from nonselective 
cation channels leading to 
depolarization of target cells. 
Silencing tools—ion pumps: 
archaerhodopsin-3 (Arch) from 
Halorubrum sodomense works 
as a proton pump and leads to 
hyperpolarization of the target 
cell such as the chloride pump 
NpHR (NpHR) from Natrono-
monas pharaonis. b Spectral 
working properties of light-
sensitive membrane proteins
- CI
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from  1-adrenergic (Opto-1AR)/2-adrenergic receptors
(Opto-2AR) or the c-terminal domain of the 5-HT1A
receptor (Rh-CT5-HT1A), intracellular signaling via PLC or
adenylyl cyclase could be elicited (Airan et al. 2009, Oh
et al. 2010). In the case of Opto-1AR light-induced Gq pro-
tein-mediated inositol triphosphate elevation led to behav-
ioral changes in freely moving mice. However, the need of
11-cis retinal is a problem for the in vivo application of
these rhodopsin hybrids. Direct optical control over second
messengers and consecutive behavioral changes in dro-
sophila were also achieved by the identiWcation and heter-
ologous expression of directly photoactivated adenylyl
cyclcases such as bPAC from the bacterium Beggiatoa sp.
(Stierl et al. 2011). Optogenetic manipulation of intracellu-
lar signaling allows phasic as well as tonic stimulation, an
interesting advantage over pharmacological approaches.
Recently another example of rhodopsin optimization was
reported by the Bamberg lab. On the search for ChR2
mutants with higher light sensitivity they identiWed a new
principle by indirectly increasing light sensitivity through
elevating calcium permeability. As described above for the
123 and 128 mutants higher light sensitivity achieved by
increasing the open state of the channel and elevating Na+
inXux was traded in for slower response kinetics. By indi-
vidually replacing each amino acid from Arg115 to Thr139,
which are located in the third transmembrane domain, the
L132C (CatCh) mutation was identiWed. CatCh has a 2.6-
fold higher Ca2+ permeability compared to wild-type ChR2.
The activation of voltage-gated Na+ channels, which is
facilitated by an increase in [Ca2+]I, elevates the internal
surface potential and thereby indirectly increases light sen-
sitivity. Moreover, the Ca2+-mediated increase in Na+ sensi-
tivity results in a faster response kinetics and improved
spike reliability of CatCh in comparison to the wild-type
ChR2 (Kleinlogel et al. 2011). Yet long-term tolerability
and functionality have to be analyzed in the living mamma-
lian brain, as calcium interference is likely to aVect intracel-
lular signaling cascades.
Targeted delivery of optogenetic tools
For most of the targeting, in vivo viral gene transfer has
been eVectively used in mice, rats and non human primates,
especially adeno-associated viruses (AAV; e.g., Sohal et al.
2009; Carter et al. 2010) lentiviruses (e.g., Adamantidis
et al. 2007; Han et al. 2009), and to a lesser extent also her-
pes simplex virus (HSV; e.g., Covington et al. 2010; Lobo
et al. 2010). Advantages of viral expression are a straight-
forward experimental approach, which takes approximately
6 weeks from virus production to extensive long lasting
opsin expression (four more weeks for HSV) and a broad
applicableness regarding the subject, ranging from rodents
to primates. Depending on the experimental setup either
strong ubiquitous promoters such as elongation factor
1-alpha (EF1), human synapsin, human thymocyte diVer-
entiation antigen 1 (Thy-1), a combination of chicken beta-
actin promoter and cytomegalovirus immediate-early
enhancer (CAG) or weaker cell type-speciWc promoters, for
example -calcium/calmodulin-dependent protein kinase II
(CamKII) can be used (Fig. 2a; Xu et al. 2001; Jakobsson
et al. 2003; Dittgen et al. 2004). AAVs are to some extent
superior to lentiviruses due to the fact that AAV-based vec-
tors remain episomally while lentiviral vectors are inte-
grated into the host genome. Thus, the expression from
lentiviral vectors is prone to inXuences of the surrounding
chromatin and the integration could lead to an undesired
disruption of host genes. General drawbacks are a limited
packing volume of AAVs and lentiviruses and weak cell
type-speciWc transcriptional promoter activity. For exam-
ple, the smallest promoter targeting selectively inhibitory
neurons is approximately 3 kilobase pairs (kb) in length,
which interferes with the maximal capacity of AAVs and
lentiviruses, which is about 5 and 8 kb, respectively
(Nathanson et al. 2009; Dong et al. 2010). A limitation
often seen in experiments using cell type-speciWc promot-
ers is the need of high irradiance for optimal stimulation of
larger brain areas. As light penetration is low in brain tis-
sue, reaching deeper regions optically requires either higher
expression levels of the rhodopsin (e.g., by using a strong
exogenous promoter as indicated above) or higher levels of
light energy. As an alternative to moderately active tissue-
or cell type-speciWc promoters, strong conditional rhodop-
sin expression can be achieved by the use of transgenic cre
recombinase driver mice (Fig. 2; Geschwind 2004; Gong
et al. 2007). By using a cre-dependent viral construct like
AAV-FlEx (Flip-Excision) or AAV-DIO (double Xoxed
inverse open reading frame) driven by a strong promoter
such as EF1 or CAG, cell and tissue speciWcity is provided
by selective cre activity (Fig. 2b; Atasoy et al. 2008; Sohal
et al. 2009). An alternative to viral injections is the use of
transgenic animals, where rhodopsin expression occurs
early in development. Several transgenic mouse lines exist,
expressing channelrhodopsin or HR under the panneuronal
Thy-1 promoter (Arenkiel et al. 2007; Wang et al. 2007;
Zhao et al. 2008) or the glutamatergic Vglut2 promoter
(Fig. 2c; Hagglund et al. 2010). In analogy to the above-
mentioned cre-dependent conditional approach utilizing
viral gene delivery systems, a cell type-speciWc expression
could be achieved by using a strong panneuronal promoter
such as EF1 or CAG in combination with the cre-loxP sys-
tem. Breeding to selective cre driver mice will result in
expression of ChR2 or NpHR driven by the panneural pro-
moter, whereas the temporal and spatial expression will
depend on the used cre driver line (Fig. 2d). For in vivo cell
type-speciWc opsin expression in utero electroporation has102 Mol Genet Genomics (2012) 287:95–109
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been used. Lacking construct size limitations even large
cell type-speciWc promoters can be used to drive expres-
sion. Depending on the day of embryonic development var-
ious brain areas and cell types can eYciently be targeted
(Saito 2006; Gradinaru et al. 2007; Navarro-Quiroga et al.
2007; Petreanu et al. 2007). Besides cell type-speciWc con-
trol in diVerent brain areas, circuit-speciWc targeting may be
desirable to distinguish more precisely between neurons,
Fig. 2 Targeted delivery of opsins to the mouse brain based on adeno-
associated viruses (AAV) or transgenic approaches. a Opsins can be
expressed in speciWc types of neurons or glia using gene-speciWc pro-
moter elements (e.g., CamKII). AAV-based expression vectors inte-
grating such promoter elements are delivered via stereotactic injection
into desired brain areas. b Stereotactic injection of AAV vectors,
which combine a strong ubiquitous promoter (e.g., Ef1 or CAG)
either with a “STOP” cassette (top) or with an AAV-FlEx/AAV-DIO
system (bottom), into speciWc cre mouse lines will result in a strong
opsin expression selectively in neurons expressing the cre recombinase.
c Classical transgenesis via pronucleus injection using a gene-speciWc
promoter (top) or targeted knock-in strategies in embryonic stem cells
(bottom) will result in a neuron- or glia-speciWc opsin expression in
transgenic mice. d Alternatively, the combination of a ubiquitous
promoter with a “STOP” cassette (top) or with an AAV-FlEx/AAV-
DIO system (bottom) can be applied also in a transgenic approach ei-
ther in a random or targeted fashion, e.g., to the ubiquitously expressed
ROSA26 locus. Only after breeding to desired cre driver lines a brain
region- or cell type-speciWc expression of opsins will be activated. Mice
expressing opsins can be recognized by the highlighted brain and an inset
in the background showing hippocampal neurons expressing opsin-GFP
fusion protein. AAV adeno-associated virus, BGHpA bovine growth hor-
mone poly A signal, GOI gene of interest, GSP gene-speciWc promoter,
IRES internal ribosomal entry side, ITR inverted terminal repeat, STOP
transcriptional terminator, UBP: ubiquitous promoter, WPRE wood-
chuck hepatitis virus posttranscriptional regulatory element
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which, although carrying the same cell-speciWc set of
genetic markers, are heterogeneous regarding their aVerent
or eVerent inXuences. By fusing cre recombinase to axo-
nally transported proteins such as wheat germ agglutinin
(WGA) and tetanus toxin fragment C (TTC) or using idio-
syncratic antero-/retrograde viral axonal delivery, circuit
connectivity can be analyzed by optogenetics in a transneu-
ronal fashion. This transcellular approach in combination
with conditional cre-dependent expression vectors repre-
sents a versatile tool for circuit mapping independent of the
use of cre animals, extending the cell type-speciWc optoge-
netic approach to animals such as rats and primates, which
have not been amenable to large-scale genetic manipulation
(Gradinaru et al. 2010).
Optogenetics is compatible with a plethora of functional 
readouts
The major advantage of optogenetics, besides genetic tar-
geting, is stimulation with light, as it oVers the possibility
of simultaneous on-site electrical measurement. Depending
on the desired resolution, optogenetics can be combined
with a variety of readouts. For in vitro proof-of-concept
experiments the most widely used methods are whole-cell
patch clamp and Weld potential recordings in combination
with optical illumination in brain slices (for example Nagel
et al.  2003; Boyden et al. 2005; Deisseroth et al. 2006;
Zhang et al. 2007a, b). To study neural activity beyond sin-
gle cells on a network level calcium imaging can be used as
a multisite indirect measurement of action potential activity
in a full optical approach (Knopfel et al. 2006). The Wrst
example of postsynaptic calcium imaging following light-
induced action potentials in ChR2-targeted presynaptic
axons was demonstrated by Zhang and Oertner (2007) to
study plasticity at single-synapse level. By using a spec-
trally compatible dye (Fluo-5F) and two-photon excitation
at 810 nm in rat hippocampal slice cultures targeted with
ChR2-tdimer2, synaptic contacts between labeled cells
could be identiWed by imaging optically induced spinal cal-
cium release. In addition, long-term potentiation of preva-
lent synaptic connections was induced (Zhang and Oertner
2007). An all-optical approach was also applied in the ini-
tial description of bidirectional optical control of neural cir-
cuits. After lentiviral transduction of murine acute cortical
slices with CaMKII::ChR2-mCherry and EF1::NpHR-
EYFP Fura-2 calcium imaging was used to measure the
eVects of optical excitation and inhibition (Zhang et al.
2007a). Because of its UV-shifted spectral properties (exci-
tation maximum at 340 nm) Fura-2 has been successfully
used in concert with ChR2 (excitation maximum at
470 nm), NpHR (excitation maximum at 590 nm) and the
OptoXRs (excitation maximum at 500 nm; Airan et al.
2009). Yet, although spectrally overlapping, genetically
encoded calcium sensors such as G-CaMP can be applied in
concert with ChR2. In a technically elegant study Guo et al.
(2009) combined in vivo optical stimulation of ChR2 wave-
length with simultaneous calcium imaging at 488 nm for
functional connectivity mapping in C. elegans neurons. By
separating an epiXuorescent high-power stimulation path
for ChR2 activation from a low-intensity laser light imag-
ing path for G-CaMP Xuorescence, unspeciWc ChR2 activa-
tion during imaging at 488 nm could be avoided although
ChR2 has its peak activation at 470 nm (Guo et al. 2009,
see also Fig. 1). Laser scanning photostimulation (LSPS)
has previously also been used in combination with gluta-
mate uncaging and whole-cell recordings to analyze synap-
tic connectivity in brain slices (Katz and Dalva 1994;
Shepherd and Svoboda 2005; Svoboda and Yasuda 2006).
By exchanging glutamate uncaging against light activation
through targeted axonal photosensitivity via ChR2, the
group of Svoboda developed ChR2-assisted circuit map-
ping (CRACM; Petreanu et al. 2007). Using in utero elec-
troporation in mice layer, 2/3 cortical neurons were targeted
with ChR2-venus and photostimulation was performed
throughout a grid covering the entire depth of the cortex.
Whole-cell current clamp recordings of Xuorescent ChR2
positive cells revealed their depolarization and detected
action potentials after perisomatic and axonal LSPS. Map-
ping postsynaptic targets of L2/3 neurons in several cortical
layers in the ipsi- and contralateral hemisphere indicated
laminar speciWcity of local and long-range cortical projec-
tions (Petreanu et al. 2007). A modiWed approach
(sCRACM) was used to study the subcellular organization
of excitatory pyramidal neurons. Local glutamate release
was measured after LSPS in conditions blocking action
potentials. EPSPs as a measure of light-induced activation
were detected only in the case of overlap between the
recorded cell and ChR2-targeted presynaptic axons.
Interestingly, subcellular mapping of neural circuitry by
sCRACM revealed that the structural connectivity of neu-
rons, as indicated by overlap of axons and dendrites, is not
always reXected by their connection on a functional level
(Petreanu et al. 2009). To study whole circuit properties
voltage-sensitive dyes (VSD) can be applied in brain slices
for an all-optical approach. As VSDs change their light
emission properties in a voltage-dependent and most nota-
bly in a millisecond time scale they are potentially well
suited to match the high temporal resolution achieved by
optogenetics (Grinvald and Hildesheim 2004). Although
compatibility can be achieved with spectrally separated
infrared dyes such as RH-155 and VSD imaging following
optical stimulation has been established successfully, it has
rarely been used experimentally up to now, most probably
due to a less favorable signal-to-noise ratio in comparison
to calcium imaging (Airan et al. 2007; Zhang et al. 2010).104 Mol Genet Genomics (2012) 287:95–109
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Another example for the study of macrocircuits and global
in vivo mapping is optical stimulation in combination with
high-resolution fMRI. Lee and colleagues showed in a
Wrst publication that blood oxygenation level-dependent
(BOLD) signals similar to classical stimulus-evoked BOLD
fMRI responses could be elicited optically. This eVect was
seen not only locally at the expression site of ChR2 in M1
CaMKII positive excitatory neurons, but also in distinct
thalamic neurons deWned by the corticofugal axonal projec-
tions (Lee et al. 2010). In a reverse approach optical stimu-
lation of ChR2 expressing cortico-thalamic projection
Wbers at the level of the thalamus was suYcient to drive not
only local thalamic BOLD signals, but also cortical signals,
most probably in an antidromic axosomatic manner. “Opto-
fMRI” or “ofMRI” has also been used to identify down-
stream targets of the primary sensory cortex (SI). Optical
stimulation of a ChR2-targeted subpopulation of SI pyrami-
dal cells evoked local BOLD signals and also in function-
ally connected network regions, with diVerences in awake
compared to anesthetized mice (Desai et al. 2011). Even
though widely hypothesized before, these experiments indi-
cate a most likely causal link between local neuronal exci-
tation and positive hemodynamic responses, although the
generation of BOLD signals may have a more complex
nature. However, functional mapping using optogenetics in
combination with fMRI not only integrates cell type speci-
Wcity and anatomical conjunction, but can also be used to
functionally dissect brain circuitries based on their connec-
tion topology (Leopold 2010). For global measurements of
brain activity in living animals, electroencephalography
(EEG) has been combined with optogenetic stimulation. In
a Wrst experiment Adamantidis et al. (2007, 2010) identiWed
the eVect of hypocretin-producing neurons in the lateral
hypothalamus on sleep to wake transition by analyzing
sleep recordings of mice with chronically implanted EEG
electrodes. In a bidirectional in vivo approach using
eNpHR and ChR2 the same group studied the eVect of
locus coeruleus neurons on wakefulness by applying EEG
and in vivo microdialysis as a functional readout (Carter
et al. 2010). For in vivo extracellular recording upon tar-
geted optical stimulation, a device called “optrode” was
created fusing a stimulating Wberoptic with a recording
electrode (Gradinaru et al. 2007, 2009). Constant technical
development even allows simultaneous recordings at multi-
ple sites in the living animal (Zhang et al. 2009; Royer et al.
2010). The foundation for using optogenetics in freely
moving rodents was set by Aravanis et al. (2007). Via a
lightweight, Xexible optical Wber called optical neural inter-
face (ONI) excitatory motor cortex neurons could selec-
tively be activated in rats and mice as measured by their
whisker movement. Several successive studies focused on
more complex behavioral paradigms as readouts for opto-
genetical manipulation such as motor behavior in animal
models of Parkinson’s disease (Gradinaru et al. 2009;
Kravitz et al. 2010), reward motivated behavior and addic-
tion (Airan et al. 2009; Tsai et al. 2009; Witten et al. 2010;
Stuber et al. 2011), fear conditioning and anxiety (Ciocchi
et al. 2010; Johansen et al. 2010; Tye et al. 2011) and other
cerebral targets such as prefrontal cortex or hypothalamus
for the study of psychiatric diseases and aggressive behav-
ior (Covington et al. 2010; Lin et al. 2011; Yizhar et al.
2011a, b).
From microbes to model organisms and beyond
Optogenetics is applicable to diverse species and animal
models. For the initial functional characterization of ChR1
and ChR2 a host model was applied that had previously
been successfully used for diVerent rhodopsins. Expression
of ChR1 and ChR2 in oocytes from Xenopus laevis in the
presence of all-trans retinal was the Wrst example of func-
tional heterologous channelrhodopsin expression outside of
algae (Nagel et al. 2002, 2003). At that moment the equa-
tion was: CHOP 1 or 2 + retinal = ChR1 or ChR2, as the
photoreceptor system from Chlamydomonas reinhardtii
was thought to be composed of channelopsin (from a
cDNA originally named CHOP1 and CHOP2 but also
termed Chlamyopsin, Cop3 or Cop4) and all-trans retinal
(Nagel et al. 2003). Deisseroth and colleagues redid the
math and prove that “CHOP2” successfully worked in rat
hippocampal primary neurons after lentiviral transduction
without adding all-trans retinal at all (although the culture
media contained little amounts of the precursor retinyl ace-
tate). By this, ChR2 was established as a new one-compo-
nent functional tool for neuroscience in mammals neither
requiring the substitution of any synthetic chemical sub-
strate nor genetic orthogonality between the rhodopsin and
the targeted host organism, even more important as there is
no mammalian analog of the algal gene CHOP2 (Boyden
et al. 2005). The Wrst in vivo applications in living animals
were put into practice in parallel by Li et al. (2005) and
Nagel et al. (2005). Transgenic expression of ChR2 speciW-
cally in cholinergic motorneurons of C. elegans allowed to
elicit behavioral responses via muscular contractions by
blue light illumination (Nagel et al. 2005). Bidirectional,
both inhibitory and excitatory in vivo control of spontane-
ous chick spinal cord activity was performed in chicken
embryos after in ovo electroporating and transient expres-
sion of ChR2 and vertebrate Ro4, respectively (Li et al.
2005). Another example of bidirectional in vivo control of
C. elegans locomotion was achieved after simultaneous
expression of ChR2 and NpHR using the muscle-speciWc
myosin promoter Pmyo-3 (Zhang et al. 2007a). As men-
tioned above C. elegans has also been used for an in vivo
all-optical interrogation of neural circuits using ChR2 andMol Genet Genomics (2012) 287:95–109 105
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G-CaMP (Guo et al. 2009). The Wrst use of optogenetics in
zebraWsh revealed that activation of zebraWsh trigeminal
neurons by ChR2 induces escape behavior even upon single
spikes, as published by Douglass et al. (2008). By using
Gal4 enhancer trapping in zebraWsh, transgenic animals can
be generated in a feasible way (Scott et al. 2007). The
Bayer lab eYciently used the GAL4/UAS system to selec-
tively express ChR2 and NpHR in speciWc neuronal sub-
populations of zebraWsh larvae. Owing to the transparent
nature of the animal in vivo functional mapping at a single
neuron resolution was performed dissecting neuronal popu-
lations involved in swim behavior, saccade generation as
well cardiac development and function (Arrenberg et al.
2009, 2010; Schoonheim et al. 2010). GAL4/UAS was also
used to introduce ChR2 into speciWc subsets of neuronal
populations (painless) in Drosophila melanogaster by
crossing transgenic UAS-ChR2 Xies with neuronspeciWc
Gal4 transgenic lines (Zhang et al. 2007c). Optical stimula-
tion of nociceptive neurons in transgenic larvae by ChR2
induced behavioral responses. However, it has to be taken
into account that D. melanogaster and zebraWsh contain
hydroxyretinal which does not enter the ChR or HR binding
sites making a substitution of all-trans retinal necessary
(for example by food supplement). Moreover, interpreta-
tion of behavioral data in D. melanogaster can be conXict-
ing as the animal has an innate behavioral light response
(Pulver et al. 2009). The species most widely investigated
with optogenetic technologies is the mouse. This is largely
owing to the vast availability of transgenic cre driver lines,
which can readily be combined with cre-dependent viral
vectors in order to facilitate strong cell-/tissue-speciWc rho-
dopsin expression (Fig. 2). As mentioned above, in mice
also classical transgenic approaches have been applied to
express ChR2 and NpHR under the control of the Thy-1
promoter. Arenkiel et al. (2007) showed strong and func-
tional, regionally restricted, channelrhodopsin expression
in Thy1::ChR2-EYFP mouse strains. By presynaptic opti-
cal manipulation of targeted cells in the bulbar-cortical cir-
cuit of the olfactory system they highlighted the potential of
optogenetics for complex circuit analysis in brain slices and
in vivo. Wang et al. (2007) used transgenic Thy1-ChR2-
YFP mice for the mapping of functional connectivity in the
neural circuitry of cortical layer VI neurons. In order to
study the role of fast spiking parvalbumin interneurons in
the generation of gamma oscillations, Thy1::ChR2-EYFP
mice were analyzed in combination with a cre-dependent
approach (Sohal et al. 2009). This animal model in combi-
nation with a cell type-speciWc lentiviral approach was also
successfully used in the systematic dissection of circuits
and deciphering of potential targets related to deep brain
stimulation in a Parkinson mouse model (Gradinaru et al.
2009). Hagglund and colleagues used BAC transgenesis to
express ChR2-EYFP under the control of the vesicular glu-
tamate receptor two promoter. These transgenic mice
express ChR2 in glutamatergic neurons of the hindbrain
and spinal cord. By optical stimulation of the lumbar region
of the spinal cord and also the caudal hindbrain rhythm
generation was observed, suggesting a role of glutamatergic
neurons in central pattern generators of locomotion (Hagglund
et al. 2010). Various examples in nematodes, mice and rats
have demonstrated a direct eVect of in vivo optogenetic
stimulation on neuronal activity and behavioral responses
(Nagel et al. 2005; Gradinaru et al. 2009; Tsai et al. 2009;
Lee et al. 2010). Yet optical control of cortical circuits in
higher organisms might be more complex: the Wrst optoge-
netic approach in primates was performed in the rhesus
macaque. Boyden and colleagues targeted speciWcally
excitatory neurons of the frontal cortex by stereotactic len-
tiviral gene delivery of ChR2-GFP driven by the CamKII
promoter and recorded neuronal activity after simultaneous
optical stimulation via an optrode (Han et al. 2009).
Besides showing the feasibility and safety of optogenetics
in primates and thereby implementing a potential clinical
translation for the use in humans, the experiments showed a
slightly discouraging, but seminal, result. Although ChR2
was targeted speciWcally to excitatory neurons a signiWcant
proportion of recorded cells showed decreased activity.
This  Wnding was previously also observed in transgenic
Thy1-ChR2 mice and is comparable to heterogeneous tis-
sue activation in the case of electrical stimulation. Thus,
targeting cortical circuits in a cell type-speciWc manner can-
not precisely predict a speciWc psychological response,
respectively, behavioral or clinical outcome. The impact of
optogenetic manipulation on cortical circuitries seems to be
heavily dependent on the neural network, in which the tar-
get cells are embedded. Nevertheless, the results indicate
important aspects for therapeutic options and suggest len-
tiviral rhodopsin delivery as a well immuno-tolerated
method for a putative application in humans.
Potential clinical applications of optoprosthetics
Recent publications underpin the possible role of optoge-
netics as a potential future therapeutic application. For
example, electrical peripheral nerve stimulation has been
used as an experimental treatment of patients with paralysis
and muscle disease. A major drawback is random or reverse
muscle recruitment by heterogeneous tissue excitation,
resulting in high fatigability. Thy-1::ChR2YFP transgenic
mice express ChR2-YFP in both the central and peripheral
nervous system as well as in lower motor and dorsal root
ganglion neurons. By an optical approach motor units can
be recruited in an orderly manner favoring small, slow
muscle Wbers in comparison to random recruitment by elec-
trical stimulation. This results in a markedly enhanced106 Mol Genet Genomics (2012) 287:95–109
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functional performance as muscle fatigability is strongly
reduced by a more physiological recruitment pattern via
optical stimulation. Taking into account recent advances in
human gene therapy the authors point out an eventual thera-
peutic use of optogenetics as neuroprosthetics and suggest
NpHR in the treatment of spastic movement disorders
(Llewellyn et al. 2010). Another promising example of
optical control replacing electrical stimulation is light-induced
stimulation of the heart muscle. Bruegmann et al. (2010)
transferred the optogenetic principle from neurons to
cardiomyocytes. A ChR2-EYFP construct driven by the
CAG promoter was electroporated into embryonic stem
cells (ESCs). After ESC diVerentiation into cardiomyocytes
ChR2 expression was limited to the cell membrane and
pulsed in vitro optical stimulation triggered action poten-
tial-induced contractions with intercellular electrical spreading.
The authors also generated transgenic CAG-ChR2-EYFP
mice that showed robust rhodopsin expression in atrial and
ventricular cardiomyoctes. By illuminating an area of only
0.05–0.2 mm with pulses as short as 1 ms, reliable action
potentials were generated in a minimally delayed 1:1 man-
ner in vitro and in vivo, allowing fast optical pacing limited
only by the natural refractoriness of the cardiac cells. Thus,
optogenetics could serve as an analytical tool for the study
of pacemaking and arrhythmia in cardiology with a high
potential for therapeutic use. There are several putative
clinical applications of optogenetics also in neurodegenera-
tive disorders. A recent work from Stroh et al. (2011)
focuses on a restorative approach. Mouse ESCs were trans-
duced in vitro via lentiviruses to express ChR2-YFP under
the EF1 promoter. After a retinoic acid-based diVerentia-
tion protocol, targeted cells were viable and electrophysio-
logically mature, similar to native cells. After FACS sorting
ChR2-YFP expressing cells were transplanted into rat
motor cortex and reacted toward blue light illumination
after integration into the host environment. Depolarization
and direct Ca2+ inXux via light-gated membrane proteins
such as ChR2 could serve as a new tool for stem cell diVer-
entiation into neural and neuronal cells in vitro and in vivo,
as various facts indicate an important role of Ca2+ dependent
cellular processes driving diVerentiation (e.g., D’Ascenzo
et al. (2006). As functional integration of the transplant is
the major goal of regenerative medicine, optogenetically
induced diVerentiation, compared to unspeciWc chemically
or electrically based protocols, just aVects the genetically
targeted graft cells within a heterogeneous cellular host
environment, reducing undesirable side eVects such as cell
death or tumor growth (Stroh et al. 2011). In a previous
study neurons derived from human ESCs were transduced
with ChR2-mCherry and mature neurons were analyzed for
synaptic integration and functional connectivity of the
targeted graft cells into the host circuitry of immuno-
depressed neonatal SCID mice (Weick et al. 2010). In vitro
postmitotic neurons, both glutamatergic and GABAergic,
showed typical electrophysiological responses upon illumi-
nation. When transplanted, ChR2 positive matured neurons
not only displayed spontaneous action potentials and post-
synaptic currents (PSCs) as a proof of input-speciWc graft
integration, but furthermore, adjacent ChR2-negative cells
likewise displayed PSCs upon light stimulation, indicating
graft to host microcircuit connectivity also in an output-
speciWc manner. By generating a pluripotent human ESC
line, expressing ChR2-mCherry constitutively under the
synapsin promoter, the authors could improve several
drawbacks of viral based approaches such as low transduc-
tion eYciency. Yet further research is necessary to establish
optogenetics as a standard examination and manipulation
tool of functional graft to host integration and circuit plas-
ticity in the context of stem cell based neuroregenerative
strategies. Another example for a clinical application could
be vision restoration in human subjects with retinal degen-
eration. ChR2- and NpHR-based approaches would, due to
their simple monocomponent working principle with good
immune compatibility, cell type speciWcity and high spatial
resolution, compete with electrical stimulation in their abil-
ity of restoring photosensitivity. In blind mice lacking reti-
nal photoreceptors (rd1 or Pde6brd1 mouse model, Bowes
et al. 1990) photosensitivity was restored by heterologous
expression of ChR2, either by transducing inner retinal neu-
rons in a non-selective viral based strategy or by in vivo
electroporating exclusively ON bipolar retinal cells using a
speciWc promoter sequence (Bi et al. 2006, Lagali et al.
2008). Positive changes in a behavioral readout indicated
improved vision and suggest the use of optogenetics in a
translational approach also in humans. A major step toward
applications in vivo, especially for therapeutic use in
humans, would be the employment of highly light-sensitive
rhodopsins with speciWcally deWned response kinetics sup-
porting optical control at a cell type-speciWc resolution. In
general optogenetics would signiWcantly beneWt from
ChRs with larger conductance and higher selectivity for
Ca2+, Na+ or K+ in combination with appropriate color and
kinetics.
Conclusions
Optogenetics has matured within a few years into a state-
of-the-art technology. This technological breakthrough
allows to tackle biological questions, which were previ-
ously out of reach of our imaginations. The major impact of
optogenetics in the upcoming years will most likely be
dominated by approaches fundamentally increasing our
comprehension of neural, as well as non-neural systems, on
a circuit level. A deeper understanding of these intricate
regulatory networks might unravel novel targets withinMol Genet Genomics (2012) 287:95–109 107
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such complex circuits, which could be suitable for thera-
peutic intervention. Optogenetics has demonstrated its
enormous potential in animal models including nonhuman
primates and thereby has raised considerable expectations
with respect to future clinical applications. However,
whether optogenetics will cross the Rubicon and will be
amenable to application in human patients will primarily
depend on similar obstacles that gene therapy has been
struggling with all along, namely eYcient and safe gene
delivery strategies.
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